Home › Funds › Avanza Fonder AB › GILD

Avanza Fonder AB position in GILD

GILEAD SCIENCES INC · Health Care

Avanza Fonder AB reported holding 155,394 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$23.2M, representing 0.44% of its reported portfolio and ranking #36 among its reported holdings. Avanza Fonder AB has disclosed GILD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)155.39K sh
Reported value held$23.16M
Portfolio Weight0.44%
First reportedQ4 2024
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Avanza Fonder AB's GILD position evolved

Avanza Fonder AB first disclosed a stake in GILD in Q4 2024 at 127,115 shares (US$11.7M). The position peaked in Q3 2026 at 155,394 shares, worth US$23.2M. Across 8 filings, Avanza Fonder AB increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 155,394 shares valued at US$23.2M — an increase of 12,751 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2024 127.11K $11.74M New
Q1 2025 119.66K $13.39M Reduce
Q2 2025 126.47K $14.02M Add
Q3 2025 127.04K $14.10M Hold
Q4 2025 130.93K $16.07M Add
Q1 2026 126.80K $17.67M Reduce
Q2 2026 142.64K $18.02M Add
Q3 2026 155.39K $23.16M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Avanza Fonder AB held GILD?

Avanza Fonder AB has disclosed GILD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Avanza Fonder AB's current position in GILD?

As of Q3 2026, Avanza Fonder AB holds 155.39K shares of GILD (GILEAD SCIENCES INC), valued at $23.16M, representing 0.44% of its reported portfolio and ranking #36.

Has Avanza Fonder AB been buying or selling GILD?

In the latest 13F filing (Q3 2026), Avanza Fonder AB increased its position in GILD. The position peaked in Q3 2026 at 155.39K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.